investors
Shanghai Haishun New Pharmaceutical Packaging Co.,Ltd. 2023 First Quarterly Report
HySum-Performance Forecast for the First Three Quarters of 2022
The financial data related to the current performance forecast has not been audited by any accounting firm.
HySum-Announcement on the Change of Business Scope of a Wholly-owned Subsidiary
HySum (Zhejiang) New Material Co., Ltd., a wholly-owned subsidiary of HySum (Shanghai) New Pharmaceutical Packaging Co., Ltd. (hereinafter referred to as the "Company"), has changed its business scope due to its business development needs.
HySum-Announcement on Resolutions of the 24th Meeting of the 4th Board of Directors
The Company and all members of the Board of Directors of the Company hereby guarantee the authenticity, accuracy and completeness of the contents of this announcement and warrant that there are no false representations, misleading statements or material omissions contained herein.